Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Sunshine Biopharma's shares outstanding was 1M at Jun 30, 2026. For fiscal 2025 it was 4M, up 492.4% from the year before. Over ten years it grew 250.2% a year on average. The highest annual figure on record is 4M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4M | +492.4% |
| FY2024 | Dec 31, 2024 | 1M | +5371.7% |
| FY2023 | Dec 31, 2023 | 0M | -91.6% |
| FY2022 | Dec 31, 2022 | 0M | +481.2% |
| FY2021 | Dec 31, 2021 | 0M | +156.0% |
| FY2020 | Dec 31, 2020 | 0M | +1765.6% |
| FY2019 | Dec 31, 2019 | 0M | +259.9% |
| FY2018 | Dec 31, 2018 | 0M | +39.4% |
| FY2017 | Dec 31, 2017 | 0M | +105.7% |
| FY2016 | Dec 31, 2016 | 0M | +253.3% |
| FY2015 | Dec 31, 2015 | 0M | +87.5% |
| FY2014 | Dec 31, 2014 | 0M | +14.3% |
| FY2013 | Dec 31, 2013 | 0M | +16.7% |
| FY2012 | Dec 31, 2012 | 0M | +50.0% |
| FY2011 | Dec 31, 2011 | 0M | 0.0% |
| FY2010 | Dec 31, 2010 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1M | -62.1% |
| Q1 FY2026 | Mar 31, 2026 | 5M | +81.5% |
| Q4 FY2025 | Dec 31, 2025 | 5M | +466.1% |
| Q3 FY2025 | Sep 30, 2025 | 5M | +331.4% |
| Q2 FY2025 | Jun 30, 2025 | 4M | +8714.2% |
| Q1 FY2025 | Mar 31, 2025 | 3M | +321.5% |
| Q4 FY2024 | Dec 31, 2024 | 1M | +5796.4% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +9768.2% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +222.7% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +191.0% |
| Q4 FY2023 | Dec 31, 2023 | 0M | -93.5% |
| Q3 FY2023 | Sep 30, 2023 | 0M | -93.2% |
| Q2 FY2023 | Jun 30, 2023 | 0M | -92.0% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +317.9% |
| Q4 FY2022 | Dec 31, 2022 | 0M | +523.5% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +642.8% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +562.4% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +140.3% |
| Q4 FY2021 | Dec 31, 2021 | 0M | +117.3% |
| Q3 FY2021 | Sep 30, 2021 | 0M | +81.0% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +212.6% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +1067.0% |
| Q4 FY2020 | Dec 31, 2020 | 0M | +3894.9% |
| Q3 FY2020 | Sep 30, 2020 | 0M | +5540.2% |
| Q2 FY2020 | Jun 30, 2020 | 0M | +3459.5% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +667.3% |
| Q3 FY2019 | Sep 30, 2019 | 0M | +230.4% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +99.2% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +82.2% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +113.0% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +10.6% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +16.8% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +16.8% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +43.8% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +242.4% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |